Shares of Covetrus CVET were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 107.69% year over year to $0.27, which beat the estimate of $0.08.
Revenue of $1,026,000,000 up by 1.68% year over year, which beat the estimate of $883,470,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: Aug 11, 2020
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/r6vu55j6
Recent Stock Performance
Company's 52-week high was at $24.13
52-week low: $4.04
Price action over last quarter: Up 92.94%
Company Description
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe, and APAC and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.